600521 logo

Zhejiang Huahai Pharmaceutical Co., Ltd. Stock Price

SHSE:600521 Community·CN¥23.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

600521 Share Price Performance

CN¥15.79
-0.24 (-1.50%)
CN¥15.79
-0.24 (-1.50%)
Price CN¥15.79

600521 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate growth potential with mediocre balance sheet.

3 Risks
1 Reward

Zhejiang Huahai Pharmaceutical Co., Ltd. Key Details

CN¥8.6b

Revenue

CN¥3.7b

Cost of Revenue

CN¥4.8b

Gross Profit

CN¥4.4b

Other Expenses

CN¥373.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
0.25
56.26%
4.36%
87.7%
View Full Analysis

About 600521

Founded
1989
Employees
8797
CEO
Bao Hua Chen
WebsiteView website
www.huahaipharm.com

Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade services. Further, it operates as a pharmaceutical company. Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989 and is headquartered in Linhai, China.

Recent 600521 News & Updates

Recent updates

No updates